Bidwell Health clinical notes

Should I Take Daily Valacyclovir for Herpes?

Last updated:
Clinically reviewed by Ashley Cranage, APRN, FNP-C

Daily valacyclovir can be a good fit for some patients with recurrent herpes, especially when outbreaks are frequent, distressing, or affecting relationships. It is not required for everyone, and a 90-day supply is not a required stopping point. Bidwell has no required subscription.

Choose herpes visitHerpes treatment options
Prior diagnosis required. Bidwell treats adults ages 18 and older who have already been diagnosed with oral or genital herpes by a healthcare provider. Bidwell does not diagnose new herpes infections online, does not require photo upload, and does not guarantee treatment.

Who is daily therapy usually for?

Daily suppressive therapy is most often considered when outbreaks are frequent, painful, disruptive, emotionally distressing, or when a patient is trying to reduce HSV-2 transmission risk with a partner. CDC guidance says suppressive therapy reduces genital herpes recurrences by about 70% to 80% in patients with frequent recurrences.

When is daily therapy not necessary?

Daily medicine may not be worth it if outbreaks are rare, mild, or easy to treat episodically. It may also be a poor fit if the diagnosis is uncertain, side effects are a problem, kidney disease requires individualized dosing, or a patient does not want daily medication.

Does daily valacyclovir prevent transmission?

It can reduce risk for some patients, but it does not eliminate risk. CDC guidance specifically describes reduced HSV-2 transmission with daily valacyclovir in discordant heterosexual couples where one partner has symptomatic genital HSV-2. Risk reduction still depends on avoiding sex during outbreaks or prodrome, condom use, and partner communication.

What about oral herpes and cold sores?

Daily valacyclovir for cold-sore prevention is off-label. Small trials studied 500 mg daily for 16 weeks in people with frequent recurrences; they do not prove that oral HSV transmission is prevented. Oral acyclovir is another off-label option for this purpose. See the valacyclovir studies and the acyclovir trial.

How does Bidwell handle renewals?

A 90-day supply describes the amount dispensed, not an instruction to stop after 90 days. Continue according to your prescription. Authorized pharmacy refills do not require another visit. When those refills are exhausted and a new prescription is needed, renewal requires a new $45 visit. Included clinical follow-up messaging lasts 21 days; medication costs are separate. Contact your clinician sooner if your health or treatment goals change. There is no required subscription.

For genital HSV-2, discuss continued suppression at least yearly, or earlier if symptoms or safety concerns change. Stopping treatment for a routine break is not required by CDC guidance.

What if I need outbreak treatment too?

Ask for a written plan distinguishing daily treatment from a breakthrough-outbreak course. Do not add, combine, or double antiviral doses yourself. Acyclovir and valacyclovir are alternative medicines, not a routine combination.

What to do if you are unsure

Questions to bring to a clinician

Related glossary terms

Does the daily dose depend on recurrence frequency?

For genital suppression in adults with normal kidney function, CDC lists valacyclovir 500 mg or 1 g daily and acyclovir 400 mg twice daily. Bidwell usually starts with 500 mg daily when appropriate; 1 g daily is another clinician-selected option for frequent outbreaks. Tell your clinician your yearly outbreak count. Valacyclovir 500 mg daily may work less well with 10 or more outbreaks per year. These genital regimens do not establish a universal cold-sore prevention dose; the clinician chooses the plan.

References

Related Bidwell pages